These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37980185)

  • 41. Intellectual Property Rights: Protection of Biotechnological Inventions in India.
    Gomase V; Kemkar K; Potnis V
    Recent Pat Biotechnol; 2024; 18(2):128-143. PubMed ID: 38282443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of knowledge, attitude and practice regarding intellectual property rights among dental task force attending private dental colleges in Navi Mumbai: a cross-sectional study.
    Kumar V; Aranha V; Bhanushali N; Jain R; Atre S; Singh S
    J Med Life; 2021; 14(1):93-99. PubMed ID: 33767792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The ethics of intellectual property rights in an era of globalization.
    Shah AK; Warsh J; Kesselheim AS
    J Law Med Ethics; 2013; 41(4):841-51, Table of Contents. PubMed ID: 24446942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Scientists' Views on the Ethics, Promises and Practices of Synthetic Biology: A Qualitative Study of Australian Scientific Practice.
    Dalziell J; Rogers W
    Sci Eng Ethics; 2023 Dec; 29(6):41. PubMed ID: 38082028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Scientific and technological innovation and achievement transformation promote the medical development].
    Zheng MH; Sun J; Jiang TY; Ma JJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jun; 23(6):541-544. PubMed ID: 32521971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.
    Wu J; Qiao J; Nicholas S; Liu Y; Maitland E
    BMC Health Serv Res; 2022 Sep; 22(1):1189. PubMed ID: 36138390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SynBio Africa's story from the grassroots, the present, and the future.
    Otim G; Matinyi S; Baluku E; Chimulwa ISG; Magoola GP; Katumba A; Mukuze S; Kyabarongo A; Opiyo SO
    Biotechnol Notes; 2023; 4():1-6. PubMed ID: 39416917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Public health, innovation and intellectual property rights: unfinished business.
    Türmen T; Clift C
    Bull World Health Organ; 2006 May; 84(5):338. PubMed ID: 16710532
    [No Abstract]   [Full Text] [Related]  

  • 49. Intellectual property rights: An overview and implications in pharmaceutical industry.
    Saha CN; Bhattacharya S
    J Adv Pharm Technol Res; 2011 Apr; 2(2):88-93. PubMed ID: 22171299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mapping the patent landscape of synthetic biology for fine chemical production pathways.
    Carbonell P; Gök A; Shapira P; Faulon JL
    Microb Biotechnol; 2016 Sep; 9(5):687-95. PubMed ID: 27489206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Freedom and Responsibility in Synthetic Genomics: The Synthetic Yeast Project.
    Sliva A; Yang H; Boeke JD; Mathews DJ
    Genetics; 2015 Aug; 200(4):1021-8. PubMed ID: 26272997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subsidies versus intellectual property rights when innovators operate in two markets.
    Skliaustyte E; Weber M
    PLoS One; 2023; 18(4):e0284880. PubMed ID: 37093831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
    Siri JGS; Fernando CAN; De Silva SNT
    Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomics. Money and machines fuel China's push in sequencing.
    Li H
    Science; 2000 May; 288(5467):795-8. PubMed ID: 10809646
    [No Abstract]   [Full Text] [Related]  

  • 56. Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
    Huang M; Wang J; Nicholas S; Maitland E; Guo Z
    J Med Internet Res; 2021 Jun; 23(6):e27345. PubMed ID: 34061761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Managing genetic material to protect intellectual property rights.
    Jong SC; Cypess RH
    J Ind Microbiol Biotechnol; 1998 Feb; 20(2):95-100. PubMed ID: 9611821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug registration application in China.
    Zhen LH
    J Pharm Pharm Sci; 2003; 6(2):211-4. PubMed ID: 12935432
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intellectual property and the commercialization of research and development.
    di Norcia V
    Sci Eng Ethics; 2005 Apr; 11(2):203-19. PubMed ID: 15915860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. China's one-child family: a famine-forced decision.
    ZPG Report; 1985; 17(2):1. PubMed ID: 12340334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.